These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1102266)

  • 41. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antibacterial activity of 6- and 7-[2-(5-carboxyimidazole-4-carboxamido)phenylacetamido]-penicillins and cephalosporins.
    Yasuda N; Iwagami H; Nakanishi E; Nakamiya T; Sasaki Y; Murata T
    J Antibiot (Tokyo); 1983 Mar; 36(3):242-9. PubMed ID: 6339459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli.
    Bobrowski MM; Matthew M; Barth PT; Datta N; Grinter NJ; Jacob AE; Kontomichalou P; Dale JW; Smith JT
    J Bacteriol; 1976 Jan; 125(1):149-57. PubMed ID: 1107303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Molecular-biological bases of the mechanism of action of penicillins and cephasporins].
    Bär H; Zarnack J
    Pharmazie; 1970 Jan; 25(1):10-22. PubMed ID: 4987180
    [No Abstract]   [Full Text] [Related]  

  • 45. [Relationship between the structure and function of polysynthetic penicillins].
    Naĭler Dzh
    Antibiotiki; 1971 Oct; 16(10):877-82. PubMed ID: 5003055
    [No Abstract]   [Full Text] [Related]  

  • 46. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative activities of cefotaxime, a new cephalosporin derivative, and of selected beta-lactam antibiotics against Haemophilus species.
    Dabernat HJ; Buu-Hoï-Dang Van A; Delmas C; Bauriaud R
    Ann Microbiol (Paris); 1979; 130 A(4):461-7. PubMed ID: 315745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The demonstration and significance of synergism between -lactam antibiotics.
    Hamilton-Miller JM
    J Med Microbiol; 1971 May; 4(2):227-37. PubMed ID: 4998855
    [No Abstract]   [Full Text] [Related]  

  • 49. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of some beta-lactam antibiotics on the morphology of some beta-lactamase and non-beta-lactamase producing strains of gram negative bacteria.
    Russell AD
    J Appl Bacteriol; 1973 Jun; 36(2):357-9. PubMed ID: 4583878
    [No Abstract]   [Full Text] [Related]  

  • 52. Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States.
    Castanheira M; Williams G; Jones RN; Sader HS
    Microb Drug Resist; 2014 Oct; 20(5):436-40. PubMed ID: 24593056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of beta-lactamases A and B in some groups of Yersinia enterocolitica and their role in resistance.
    Cornelis G
    J Gen Microbiol; 1975 Dec; 91(2):391-402. PubMed ID: 1043915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.
    Verbist L
    Antimicrob Agents Chemother; 1982 Jul; 22(1):157-61. PubMed ID: 6982023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Probability of resistance to 10 standard- and 7 recently introduced antimicrobics in multiresistant strains of Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)].
    Schröter G; Hümpfner A
    Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):31-42. PubMed ID: 375624
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of cefazolin against dense populations of enterobacteria.
    Greenwood D; Chan-Teoh CH; O'Grady F
    Antimicrob Agents Chemother; 1975 Feb; 7(2):191-5. PubMed ID: 1137370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases.
    Greenwood D; Pearson NJ; O'Grady F
    J Antimicrob Chemother; 1976 Dec; 2(4):337-43. PubMed ID: 802124
    [No Abstract]   [Full Text] [Related]  

  • 60. A possible role of R plasmids in bacterial permeability for beta-lactam antibiotics.
    Ikeuchi T; Osada Y
    Microbiol Immunol; 1981; 25(4):333-44. PubMed ID: 7019627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.